^
11ms
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors (clinicaltrials.gov)
P1, N=10, Active, not recruiting, Seattle Children's Hospital | Recruiting --> Active, not recruiting | N=48 --> 10
Enrollment closed • Enrollment change
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 positive
|
HER2-Specific CAR T